Netherlands National Drug Monitor - Research and Documentation ...

Table 5.4a Use of amphetamines and Ecstasy in the general population of a number of EU-15
member states and Norway: age group 15 to 64
Country Year Ecstasy Amphetamine
Ever Recent Ever Recent
Spain 2005/2006 4.4% 1.2% 3.4% 0.7%
The Netherlands 2005 4.3% 1.2% 2.1% 0.3%
Ireland 2006/2007 5.4% 1.2% 3.5% 0.4%
Austria 2004 3.0% 0.9% 2.4% 0.8%
Italy 2005 2.5% 0.5% 2.4% 0.4%
France 2005 2.0% 0.4% 1.4% 0.1%
Norway 2004 1.8% 0.5% 3.6% 1.1%
Finland 2006 1.6% 0.5% 2.2% 0.6%
Portugal 2007 1.3% 0.4% 0.9% 0.2%
Greece 2004 0.4% 0.2% 0.1% 0.0%
Belgium 2001 - - 2.1% -
Differences in survey year, measuring methods and sampling hamper a precise comparison between countries.
Percentage of ever users and recent users (past year) - = not measured. Source: EMCDDA
Table 5.4b Ecstasy and amphetamine use in the general population of a number of EU-15 member
states, the US, Canada and Australia: other age groupsI
Country Year Age Ecstasy Amphetamine
Ever Recent Ever Recent
Australia 2007 14 + 8.9% 3.5% 6.3% 2.3%
The U.K.
(England & Wales)
2006/2007 16-59 7.3% 1.8% 11.9% 1.3%
US 2008 12 + 5.2% 0.9% 8.5% 1.1%
Canada 2004 15 + 4.1% 1.1% 6.4% 0.8%
Germany 2006 18 - 64 2.0% 0.4% 2.5% 0.5%
Denmark 2005 16 - 64 1.8% 0.3% 6.9% 0.7%
Sweden 2000 16 - 64 0.2% 0.2% 1.9% 0.2%
Differences in survey year, measuring methods and sampling hamper a precise comparison between
countries. Percentage of ever use and recent use (past year). I. Drug use is relatively low in the youngest
age groups (12-15) and in the oldest age groups (>64). Usage figures in studies with respondents who are
younger and/or older than the EMCDDA-standard may be lower than in studies that use the EMCDDAstandard.
The opposite will be true for studies using a more restricted age range. Sources: EMCDDA, AIHW,
SAMSHA, CAS.
114 Netherlands National Drug Monitor - NDM Annual Report 2009